IMVT - Immunovant, Inc.

QQQ $ 432.04 $ 4.05 (0.95 %)

DIA $ 382.89 $ 2.12 (0.56 %)

SPY $ 509.43 $ 1.24 (0.24 %)

TLT $ 88.28 $ 0.01 (0.01 %)

GLD $ 216.32 $ -0.96 (-0.44 %)

Previous Close

$ 27.75

Open

$ 27.56

Bid

$ 24.68 x 100

Ask

$ 30.11 x 100

Day's Range

$ 27.20 - $ 27.94

52 Week Range

$ 15.90 - $ 45.58

Volume

1,270,174

Average Volume

Market Cap

4.01B

Beta (5Y Monthly)

$ 1.28

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-12-2024	12-31-2023	10-Q
2	11-09-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-22-2023	03-31-2023	10-K
5	02-03-2023	12-31-2022	10-Q
6	11-04-2022	09-30-2022	10-Q
7	08-05-2022	06-30-2022	10-Q
8	06-08-2022	03-31-2022	10-K
9	02-04-2022	12-31-2021	10-Q
10	11-05-2021	09-30-2021	10-Q
11	08-09-2021	06-30-2021	10-Q
12	06-01-2021	03-31-2021	10-K
13	02-16-2021	12-31-2020	10-Q
14	11-12-2020	09-30-2020	10-Q
15	08-12-2020	06-30-2020	10-Q
16	06-29-2020	03-31-2020	10-K
17	02-14-2020	12-31-2019	10-Q
18	11-13-2019	09-30-2019	10-Q
19	08-12-2019	06-30-2019	10-Q
20	06-12-2019	03-31-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Initiates Coverage On Immunova...
03/28/2024 10:49:49

Oppenheimer analyst Leland Gershell initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Pr...

Truist Securities Reiterates Buy on Immuno...
03/25/2024 16:11:34

Truist Securities analyst Robyn Karnauskas reiterates Immunovant (NASDAQ:IMVT) with a Buy and maintains $48 price target.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/21/2024 13:05:49

Goldman Sachs Initiates Coverage On Immuno...
03/13/2024 12:38:42

Goldman Sachs analyst Corinne Johnson initiates coverage on Immunovant (NASDAQ:IMVT) with a Buy rating and announces Price T...

Immunovant Awarded U.S. Patent for IMVT-1402
03/12/2024 11:32:37

Wolfe Research Initiates Coverage On Immun...
02/15/2024 11:40:04

Wolfe Research analyst Andy Chen initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Price...

Recap: Immunovant Q3 Earnings
02/12/2024 13:00:06

Immunovant Q3 EPS $(0.36) Up From $(0.49) ...
02/12/2024 12:11:54

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.36) per share. This is a 26.53 percent increase over losses of $(0.49...

why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why CarMax Shares Are Trading Higher By Ar...
12/21/2023 18:01:44

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

B of A Securities Maintains Buy on Immunov...
12/21/2023 16:29:59

B of A Securities analyst Jason Gerberry maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from $49 ...

autoimmune-disease-player-immunovants-investigational-drug-for-immune-system-disorder-shows-response-rates-of-over-50

Autoimmune Disease Player Immunovant's Inv...
12/21/2023 13:57:55

Immunovant Inc (NASDAQ: IMVT), on Thursday, released the results from the initial cohort of patients in an ongoing 24-week Phas...

Amazon.com To Rally Over 38%? Here Are 10 ...
12/21/2023 12:36:23

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

HC Wainwright & Co. Maintains Buy on Immun...
12/21/2023 11:09:49

HC Wainwright & Co. analyst Douglas Tsao maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from ...

micron-posts-upbeat-sales-joins-calliditas-therapeutics-and-other-big-stocks-moving-higher-in-thursdays-pre-market-session

Micron Posts Upbeat Sales, Joins Callidita...
12/21/2023 10:27:25

U.S. stock futures were higher this morning, with the Dow Jones futures gaining more than 150 points on Thursday.

Immunovant Says Results From Initial Cohor...
12/20/2023 21:32:36

Batoclimab was generally well tolerated with no new safety signals observed in the initial data set.

why-steelcase-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Steelcase Shares Are Trading Lower By ...
12/20/2023 18:16:08

Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results.

fedex-posts-downbeat-earnings-joins-steelcase-argenx-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

FedEx Posts Downbeat Earnings, Joins Steel...
12/20/2023 10:33:14

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 30 points on Wednesday.

Deutsche Bank Initiates Coverage On Immuno...
12/12/2023 10:11:33

Deutsche Bank analyst Neena Bitritto-Garg initiates coverage on Immunovant (NASDAQ:IMVT) with a Buy rating and announces Pri...

Analyst Ratings for Immunovant
12/01/2023 20:00:38

UBS Maintains Buy on Immunovant, Raises Pr...
12/01/2023 18:30:26

UBS analyst Colin Bristow maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from $55 to $56.